organic heterocyclic compound myxothiazol 0 487.19633 487.691 pubmed:6752659 pubmed:24414973 CO/C(=C/C(N)=O)[C@H](C)[C@H](/C=C/c1csc(-c2csc([C@@H](C)/C=C/C=C/C(C)C)n2)n1)OC pubmed:2846049 pubmed:16081299 pubmed:7247372 (2E,4R,5S,6E)-3,5-dimethoxy-4-methyl-7-{2'-[(2S,3E,5E)-7-methylocta-3,5-dien-2-yl][2,4'-bi-1,3-thiazol]-4-yl}hepta-2,6-dienamide pubmed:10853768 pubmed:24661880 (2E,4R,5S,6E)-3,5-dimethoxy-4-methyl-7-{2'-[(2S,3E,5E)-7-methylocta-3,5-dien-2-yl][2,4'-bi-1,3-thiazol]-4-yl}hepta-2,6-dienamide knapsack:C00018319 pubmed:11134965 C25H33N3O3S2 pubmed:31079230 pubmed:12176058 pdb-ccd:MYX (+)-myxothiazol pubmed:11237706 metacyc.compound:CPD0-1244 chebi_ontology cas:76706-55-3 drugbank:DB04741 pubmed:2753821 pubmed:15312779 pubmed:7271921 pubmed:29402945 kegg.compound:C15674 XKTFQMCPGMTBMD-FYHMSGCOSA-N CHEBI:44129 pubmed:18221415 A 2,4'-bi-1,3-thiazole substituted at the 4-position with a (1<i>E</i>,3<i>S</i>,4<i>R</i>,5<i>E</i>)-7-amino-3,5-dimethoxy-4-methyl-7-oxohepta-1,5-dien-1-yl] group and at the 2'-position with a (2<em>S</em>,3<i>E</i>,5<i>E</i>)-7-methylocta-3,5-dien-2-yl group. It is an inhibitor of coenzyme Q - cytochrome c reductase. (+)-myxothiazol A pubmed:6274398 Myxothiazol A InChI=1S/C25H33N3O3S2/c1-16(2)9-7-8-10-17(3)24-28-20(15-33-24)25-27-19(14-32-25)11-12-21(30-5)18(4)22(31-6)13-23(26)29/h7-18,21H,1-6H3,(H2,26,29)/b9-7+,10-8+,12-11+,22-13+/t17-,18+,21-/m0/s1 CHEBI:25461 wikipedia.en:Myxothiazol carboxamide